| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dd7a477d049ed5da4371c2253b277938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da82e01e977e9f538028c04419ceacdd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_047b370f90a0fcd26b402d7bc90d9b63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_beefcba275ff0d8342e8cc8aee71b32e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0c1e26c1121d4c4d2c8c6f9f08578951
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85d018d0ccb94436b58eae0788bb2565 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C10N2010-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6881
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2009-02-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b98f09cceccc053c56a6afaad4c6517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9b608692bd2a2d2318078758127e19c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_774f5feef590500b9a34e6efe7ed48e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_15bd3a8ff30913b927ba9d5b3f12e040
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aea0485764f72c4144362b46926788ee |
| publicationDate |
2009-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009101083-A1 |
| titleOfInvention |
Psmb10: a diagnosis marker and therapeutic target of chronic rejection |
| abstract |
The present invention relates to a method for diagnosing chronic graft rejection of a grafted organ in a subject from a biological sample of said subject, comprising: (a) determining in vitro an expressionlevel value for PSMB10 in said subject biological sample, (b) comparing said value to at least one reference expression level value for PSMB10 in at least one reference sample, and (c) diagnosing if said subject is or not undergoing chronic rejection of said grafted organ.The invention also concerns a diagnostic kit or microarray for performing the method of the invention. The invention further concerns the medical use of proteasome inhibitors for treating chronic rejection. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108440571-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10451636-B2 |
| priorityDate |
2008-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |